Skip to content

Dexamethasone With TAP Block Increasing the Duration of the Peripheral Nerve Block in Caesarian Section

Dexamethasone With TAP Block Increasing the Duration of the Peripheral Nerve Block in Caesarian Section

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02440880
Enrollment
150
Registered
2015-05-12
Start date
2015-05-31
Completion date
2017-01-31
Last updated
2016-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Nowadays Cesarean sections became the most popular surgery worldwide with the consumption of the hospital resources and the continuous need to decrease the costs, work load and medical stuff engagement. One of the most common problem is the need to control pain post operatively, this issue increase the work load over the pain management team and increase lead to patient in satisfaction. This study will test the usage of dexamethasone with different doses (4 and 8 mg) either locally or intravenously (I.V.) with the local anesthetics in TAP (transversus abdominis plane) block to prolong the duration of the block and decrease the need of post-operative analgesics.

Detailed description

Nowadays Cesarean sections became the most popular surgery worldwide with the consumption of the hospital resources and the continuous need to decrease the costs, work load and medical stuff engagement. One of the most common problem is the need to control pain post operatively, this issue increase the work load over the pain management team and increase lead to patient in satisfaction.(1,2,3) The presence of the adjuvant which can be added to the conventional anesthetic medications can prolong the duration of action and decrease the need for frequent post-operative analgesics.(4,5) The idea of adding a catheter or placing an epidural catheter still have a quite limitation regarding the patients compliance, delayed ambulation and high costs, these limitations redirect the anesthetist again to the use of adjuvant with a single shot block to prolong the duration of it and decrease the need of subsequent analgesics.(6) Dexamethasone proved to be an effective adjuvant in prolongation of the nerve blocks with the question regarding the proper route and dose (7,8,9,10). This study will test the usage of dexamethasone with different doses (4 and 8 mg) either locally or intravenously (I.V.) with the local anesthetics in TAP (transversus abdominis plane) block to prolong the duration of the block and decrease the need of post-operative analgesics.

Interventions

DRUGDexamethasone in addition to TAP block in dose of 4 mg

Dexamethasone in addition to TAP block in dose of 4 mg

DRUGDexamethasone in combination with TAP block in dose of 8 mg

Dexamethasone in combination with TAP block in dose of 8 mg

DRUGDexamethasone intravenous 4mg+ TAP block

Dexamethasone intravenous in addition to TAP block in dose of 4 mg

DRUGDexamethasone intravenous in addition to TAP block in dose of 8 mg

Dexamethasone intravenous + TAP block in dose of 8 mg

OTHERcontrol

TAP block without Dexamethasone neither intravenous nor in combination with the block

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Any patient ASA (american society of anesthesia) I or II, * aged between 18 and 45 scheduled for elective cesarean section.

Exclusion criteria

* patient refusal, * age below 18 or above 45 years, * coagulopathy with INR (international normalized ratio) more than 1.5 or platelets below 100000, * uncontrolled diabetes, uncontrolled hypertensive, addict patient, * psychological instability, and * allergy to the used drugs, * failure of spinal, * conversion to general of anesthesia, * failure of application of TAP block.

Design outcomes

Primary

MeasureTime frame
level of pain according to verbal analogue scaleTHREE DAYS

Countries

Egypt

Contacts

Primary ContactHassan Ali
hassan364@hotmail.com+201001733687

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026